INSUS consolidates monitoring, qualification and batch record evidence against EU GMP Annex 1 requirements, and flags approaching deadlines and gaps for the quality team to close. Quality teams keep every determination and sign-off.
01
It tracks, checks and flags. It never self-certifies.
02
No monitoring or testing is performed. Only records are read.
03
Quality signs off before anything enters the system of record.
The problem
Annex 1 sets grade-dependent particle and microbial limits, guidance values such as differential pressure between rooms, and named frequencies for cleanroom requalification, sterilisation revalidation and gowning reassessment. It also expects interventions, sterilisation cycles and hold times to be documented in the batch record. A Contamination Control Strategy must show ongoing conformance, yet the evidence often sits in separate systems. Approaching deadlines and documentation gaps are frequently found close to a review or inspection.
The shift
Quality judgement and sign-off stay where they are. What changes is whether evidence is checked continuously against named requirements instead of rebuilt reactively.
Today
With INSUS
How it works
Delivered through ExpertFlow AI as document intelligence over contamination control records. It organizes and checks evidence. It does not perform environmental monitoring, qualification testing or certify compliance.
Connect
Connect existing environmental monitoring data, requalification and revalidation records, QMS and MES or batch records including intervention logs and sterilisation cycle identifiers, hold-time records and the current Annex 1 text.
Understand
Map monitoring and qualification records against the grade-dependent limits and named frequencies that apply to each room, grade and piece of equipment.
Identify
Surface approaching requalification and revalidation deadlines, monitoring results trending toward a limit, and batch record gaps such as a missing intervention log or incomplete hold-time record.
Advise
Present a prioritized list of documentation and scheduling actions ranked by deadline proximity and regulatory significance, with evidence mapped to each named control element for review.
Verify
Quality teams review and sign off every assembled documentation update and flagged trend before it becomes part of the system of record.
Getting started
For sterile biologics and cell and gene therapy quality teams. Delivered through ExpertFlow AI as document intelligence and deadline tracking. Expert Services can help with discovery and validation. Advisory only. No new sensors. Does not touch plant control systems.
Related for biotech
Annex 1 contamination control strategy sits beside cell culture titer optimization and AAV affinity purification optimization on the same biologics operation.
Annex 1 requires continuous contamination control evidence across monitoring, requalification and batch records. This use case consolidates that evidence, checks it against named requirements and flags gaps for quality-team review.
Existing monitoring results, requalification and revalidation records, hold-time records and batch documentation for rooms and equipment in scope. No new sensors. It organizes records from testing you already perform.
No. It does not predict physical outcomes. It retrieves and links records, tracks deadlines, analyzes monitoring trends in documentation terms and flags gaps for human review.
No. It has no authority to certify conformance, release a batch or independently schedule qualification or validation activity.
No. The quality team reviews and signs off every update and owns every compliance and scheduling decision. Integration is with quality, batch record and qualification systems, not plant control systems.
Through ExpertFlow AI as document intelligence over contamination control records. Expert Services can support discovery, integration and validation with your quality team.
Usefulness depends on accessible underlying records. The system flags gaps for human review; it does not make regulatory determinations or replace GMP procedures.
Biotech · EU GMP Annex 1
Start with one sterile manufacturing suite. The useful first answer is which deadlines and documentation gaps are already close, while there is still lead time to act on them.
